The Filing Desk

Carlsmed vs LENSAR

Carlsmed CARL · LENSAR LNSR · Health Care Equipment

LENSAR reported revenue of $58 million in fiscal 2025, 1.2 times Carlsmed's $50 million in fiscal 2025. Carlsmed's revenue grew 85.9% in its latest year, and LENSAR's grew 9.2%. Carlsmed had an operating margin of -60.5%, against -42.1% at LENSAR. Free cash flow was −$30 million at Carlsmed and −$15 million at LENSAR.

Side by side

CarlsmedLENSAR
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$50M$58M
Revenue growth85.9%9.2%
Revenue growth a year, last 5 years—17.2%
Gross margin75.3%46.4%
Operating margin−60.5%−42.1%
Net margin−58.7%−58.7%
Free cash flow−$30M−$15M
Free cash flow margin−58.6%−25.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count249.7%3.8%
Last close$17.22$4.64
P/E at the last close——
Insider trades, last 12 monthssold $2.6 millionsold $169,989
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CarlsmedLENSAR
Operating margin
Percent of revenue
CarlsmedLENSAR
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CarlsmedLENSAR

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Carlsmed and LENSAR pages.